A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 9,333 shares of DYN stock, worth $223,712. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,333
Previous 9,333 -0.0%
Holding current value
$223,712
Previous $335,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$31.94 - $47.04 $670 - $987
-21 Reduced 0.22%
9,333 $335,000
Q2 2024

Jul 29, 2024

SELL
$23.65 - $35.63 $496 - $748
-21 Reduced 0.22%
9,354 $330,000
Q1 2024

Apr 25, 2024

BUY
$13.06 - $29.18 $13,007 - $29,063
996 Added 11.89%
9,375 $266,000
Q3 2023

Oct 25, 2023

BUY
$8.6 - $12.18 $26,591 - $37,660
3,092 Added 58.48%
8,379 $75,000
Q2 2023

Aug 07, 2023

BUY
$8.53 - $14.28 $45,098 - $75,498
5,287 New
5,287 $59,000

Others Institutions Holding DYN

About Dyne Therapeutics, Inc.


  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $1.24B
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.